Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy
Etienne Vincens(Institut Gustave Roussy), Philippe Morice(Inserm)
Cited by 105
Related Papers
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
|Annals of Oncology|2019|1.2k
ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease
|Annals of Oncology|2024|277
Uterine serous carcinoma
|Gynecologic Oncology|2021|158
European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery
|International Journal of Gynecological Cancer|2016|141